Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions
Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
This research is studying the preventative use of topical 0.1% tazarotene gel daily in
addition to best practice standards to reduce the development of hand-foot skin reaction
(HFSR).